SEC Filing Update: #LXEO Lexeo Therapeutics, Inc. : $4.96
Sector: Healthcare | YTD: π½ -48.44%
The SEC disclosed Today (13-AUG-2026) that AFFINITY ASSET ADVISORS, LLC has INCREASED #LXEO Shares by 14.93% π’
* Previous Holdings: 5.81M Shares
* Current Holdings: 6.67M Shares
* Increase+867.30K
* Increased(%)+14.93%
* Ownership: 8.4%
* Estimated Investment Value: $3.98M
https://www.thinksabio.com/reports/isr/LXEOInstitutional ownership in #LXEO has been steadily rising over the past 5 quarters in Shares:
Q1 2025: 28.01M
Q2 2025: 42.27M
Q3 2025: 49.36M
Q4 2025: 76.46M
Q1 2026: 79.89M
π Institutional activity in the last 30 days for #LXEO:
β’ STATE STREET CORP β Increased holdings by 786,533 shares (07-AUG-2026)